Barbados vs Trinidad and Tobago: Estimated antiretroviral therapy coverage among people living with HIV
Barbados
67.0%
in 2025
Trinidad and Tobago
66.0%
in 2025
Barbados rank
92nd
Trinidad and Tobago rank
95th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Barbados
- Trinidad and Tobago
How they compare
Barbados currently reports 67.0% against 66.0% in Trinidad and Tobago, a difference of 1.0%.
The two have swapped places 5 times across 26 shared years of data; in 2000 it was Trinidad and Tobago ahead.
Barbados ranks 92nd and Trinidad and Tobago ranks 95th of 143 countries.
Across the 3 decades both report, Barbados averaged higher in 2 and Trinidad and Tobago in 1.
Head to head by decade
| Decade | Barbados | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.4% | 12.2% | 8.2% | Barbados |
| 2010s | 52.7% | 54.9% | 2.2% | Trinidad and Tobago |
| 2020s | 64.8% | 64.0% | 0.8% | Barbados |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Barbados or Trinidad and Tobago?
- Barbados, at 67.0% against 66.0% in Trinidad and Tobago as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Barbados and Trinidad and Tobago?
- 1.0%, with Barbados ahead.
- How many years of comparable data are there for Barbados and Trinidad and Tobago?
- 26 years are reported by both, from 2000 to 2025.
- How do Barbados and Trinidad and Tobago rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Barbados ranks 92nd and Trinidad and Tobago ranks 95th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.